(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ Composite: PACB) jumped 6.71% to $29.44 at 16:24 EST on Friday, after two sequential sessions in a row of losses. NASDAQ Composite is falling 0.91% to $15,043.97, after five successive sessions in a row of losses. This seems, up to now, a somewhat negative trend exchanging session today.

Pacific Biosciences of California’s last close was $31.23, 41.83% under its 52-week high of $53.69.

Volume

Today’s last reported volume for Pacific Biosciences of California is 2902906 which is 46.09% above its average volume of 1987000.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 63.1% for the present quarter and 39.6% for the next. The company’s growth estimates for the current quarter and the next is a negative 50% and a negative 164.9%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $29.44 at 16:24 EST, way under its 52-week high of $53.69 and way above its 52-week low of $7.68.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is under its 50-day moving average of $29.98 and below its 200-day moving average of $30.00.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here